The cancerogenic potential of primary human Cholangioracinoma cells is inhibited by Obeticholic Acid, a Farnesoid X Receptor (FXR) agonist

Authors :: Vincenzo Cardinale
M.C. Bragazzi
D. Costantini
Gian Luca Grazi
Domenico Alvaro
P.B. Berloco
S. Safarikia
Eugenio Gaudio
L. Nevi
Guido Carpino
S. Di Matteo
A.M. Derose
Chiara Napoletano
E. Manzi
Felice Giuliante
F. Giulitti
Fabio Melandro
M. Colantonio
Source :: Digestive and Liver Disease. 50:22-23
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Agonist
chemistry.chemical_compound
Hepatology
chemistry
medicine.drug_class
business.industry
Gastroenterology
medicine
Obeticholic acid
Farnesoid X receptor
Pharmacology
business

Tools